Salix confirms Endo's rival buyout proposal
MLex Summary: Salix Pharmaceuticals confirmed Wednesday that it has received an unsolicited proposal from Endo International to acquire all of the outstanding shares of common stock of the company for a combination...To view the full article, register now.
Already a subscriber? Click here to view full article